Gray matter network properties show distinct associations with CSF p-tau 181 levels and amyloid status in individuals without dementia
Luigi Lorenzini(Amsterdam Neuroscience), Betty M. Tijms(Amsterdam Neuroscience), John T. O’Brien(North Tyneside General Hospital), Kaj Blennow(Sahlgrenska University Hospital), Viktor Wottschel(University of Geneva), Philip Scheltens(Amsterdam University Medical Centers), Pieter Jelle Visser(Karolinska Institutet), Craig Ritchie(Western General Hospital), Henk Mutsaerts(Amsterdam Neuroscience), Pierre Payoux(Université Toulouse III - Paul Sabatier), Pablo Martínez‐Lage(Fundacion CITA Alzheimer), Silvia Ingala(Amsterdam Neuroscience), Sven Haller(Ulsan College), Adam Waldman(Royal Society of Edinburgh), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Juan Domingo Gispert(Lund University), Alle Meije Wink(University of Cambridge), Joanna M. Wardlaw(University of Edinburgh), B Frisoni(University of Geneva), Gaël Chételat(Inserm)
Cited by 3
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k